Stock comparison

JNJvsTSLA

Johnson & Johnson vs Tesla Inc. Real data pulled from the alphactor.ai fundamentals pipeline — valuation, balance-sheet health, momentum, and analyst sentiment side by side.

JNJ

Johnson & Johnson

$234.18

+16.15%

Pharmaceuticals$585.7BNYSE
TSLA

Tesla Inc

$400.62

-15.69%

Automobiles$1.45TNASDAQ

60-day price, rebased to 100

JNJ +7.18% · TSLA -6.92%

Round-by-round

JNJ 2·TSLA 3· 1 tie
EdgeJNJ

Valuation upside

-49.50% vs -92.30% to DCF fair value

EdgeTSLA

Balance-sheet strength

Altman Z 5.48 vs 33.68

Tie

Fundamental quality

Piotroski 4.00 vs 4.00 (of 9)

EdgeTSLA

Growth + margins

Rule-of-40 -5.70 vs 18.90

EdgeJNJ

60-day momentum

+7.18% vs -6.92% price return

EdgeTSLA

Market-cap liquidity

$585.7B vs $1.45T

Verdict

Across 6 categories, TSLA takes the edge with 3 wins to 2 (and 1 tie). Neither score is a buy signal on its own: run the full backtest and credibility tests on alphactor.ai before putting money on it.

Backtest a strategy on JNJ or TSLA

Point-in-time backtests, 8-layer credibility pipeline, conviction scoring — free to start.

For informational and educational purposes only. Not financial advice. Learn more